295 related articles for article (PubMed ID: 32557733)
1. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
3. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
[TBL] [Abstract][Full Text] [Related]
4. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
5. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin in pediatric patients maintained on extracorporeal life support.
Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK
Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880
[TBL] [Abstract][Full Text] [Related]
7. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
8. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
[TBL] [Abstract][Full Text] [Related]
10. Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy.
Walker EA; Roberts AJ; Louie EL; Dager WE
ASAIO J; 2019 Feb; 65(2):134-138. PubMed ID: 29538017
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Hamzah M; Jarden AM; Ezetendu C; Stewart R
Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633
[TBL] [Abstract][Full Text] [Related]
12. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
[TBL] [Abstract][Full Text] [Related]
13. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
[TBL] [Abstract][Full Text] [Related]
14. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME
Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation.
Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO
Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation.
Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS
ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
Dangas GD; Lefèvre T; Kupatt C; Tchetche D; Schäfer U; Dumonteil N; Webb JG; Colombo A; Windecker S; Ten Berg JM; Hildick-Smith D; Mehran R; Boekstegers P; Linke A; Tron C; Van Belle E; Asgar AW; Fach A; Jeger R; Sardella G; Hink HU; Husser O; Grube E; Deliargyris EN; Lechthaler I; Bernstein D; Wijngaard P; Anthopoulos P; Hengstenberg C;
J Am Coll Cardiol; 2015 Dec; 66(25):2860-2868. PubMed ID: 26477635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
